Daniel Gorman

Dr. Daniel Gorman’s clinical and academic interests include attention-deficit/hyperactivity disorder, Tourette syndrome, obsessive-compulsive disorder, child psychopharmacology, and medical education. He has authored or co-authored over 30 articles and book chapters, mainly related to childhood neuropsychiatric disorders and their pharmacological management. He also contributed to Canadian guidelines on cardiac risk assessment before the use of stimulants, management of tic disorders, and pharmacotherapy for childhood disruptive and aggressive behaviour. He is a member of the Research and Scientific Program Committee of the Canadian Academy of Child and Adolescent Psychiatry, and completed a term as its Chair (2011–2014). He also completed two terms as the Director of Postgraduate Education for the Division of Child and Youth Mental Health, University of Toronto (2014–2022).

Research

The major themes of Gorman’s research have been to contribute to a better understanding of psychiatric disorders in childhood and adolescence, and to synthesize available information regarding evidence-based treatments for these disorders. His earlier research focused on using neuroimaging techniques to explore the neurobiological basis of childhood neuropsychiatric conditions, specifically Tourette syndrome, attention-deficit/hyperactivity disorder (ADHD), and obsessive-compulsive disorder. A related research interest was the natural course of these conditions. Later he became involved in knowledge synthesis and dissemination, contributing to Canadian guidelines on cardiac risk assessment before the use of stimulants, management of tic disorders, and pharmacotherapy for childhood disruptive and aggressive behaviour. He also contributed to a systematic review and meta-analysis of pharmacological treatment of ADHD symptoms in children and youth with autism spectrum disorder.

Education and experience

• 2012–present: Locum Physician, Psychiatry, Sault Area Hospital, Sault Ste. Marie, ON
• 2005–present: Physician, Psychiatry, The Hospital for Sick Children, Toronto, ON
• 2010–2012: Education Scholars Program, Centre for Faculty Development, Faculty of Medicine, University of Toronto, Toronto, ON
• 2003–2005: Research Fellowship, Child and Adolescent Psychiatry, National Institute of Mental Health Institutional Research Training Program, Columbia College of Physicians and Surgeons/New York State Psychiatric Institute, New York, NY
• 2001–2003: Clinical Fellowship, Child and Adolescent Psychiatry, Boston Children’s Hospital and Harvard Medical School, Boston, MA
• 1998–2001: Psychiatry Residency, New York‐Presbyterian Hospital and Weill Cornell Medical Center (Payne Whitney Clinic), New York, NY
• 1994–1998: MD Program, Faculty of Medicine, University of Toronto, Toronto, ON

Achievements

• 2023: Excellence in Postgraduate Medical Education Award in the Category of Teaching Performance, Mentorship, and Advocacy, Faculty of Medicine, University of Toronto, Toronto, ON
• 2011: Robin Hunter Award for Postgraduate Teaching in Psychiatry, Department of Psychiatry, University of Toronto, Toronto, ON
• 2011: Research Award (Co-recipient), Tourette Canada (awarded to the research team that developed the “Canadian Guidelines for the Evidence-Based Treatment of Tourette Syndrome”)
• 2010: Medical Award, Tourette Canada (presented in recognition of a doctor or other clinician for outstanding service to individuals with Tourette syndrome)
• 2007: Psychiatry Postgraduate Teaching Award, The Hospital for Sick Children, Toronto, ON
• 2006: Paul Steinhauer Award for Postgraduate Teaching in Child Psychiatry, Department of Psychiatry, University of Toronto, Toronto, ON

1. Gorman D, Gardner D, Murphy A, Feldman M, Bélanger M, Steele M, Boylan K, Cochrane-Brink K, Goldade R, Soper P, Ustina J, Pringsheim T. Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder. Can J Psychiatry. 2015 Feb;60(2):62-76. 
2. Pringsheim T, Hirsch L, Gardner D, Gorman D. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with disruptive behaviour disorders: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers. Can J Psychiatry. 2015 Feb;60(2):52-61. 
3. Pringsheim T, Hirsch L, Gardner D, Gorman D. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with disruptive behaviour disorders: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine. Can J Psychiatry. 2015 Feb;60(2):42-51. 
4. Gorman D, Thompson N, Plessen K, Robertson M, Leckman J, Peterson B. Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study. Br J Psychiatry. 2010;197:36‐44. 
5. Gorman D, Zhu H, Anderson G, Davies M, Peterson B. Ferritin levels and their association with regional brain volumes in Tourette syndrome. Am J Psychiatry. 2006;163:1264‐1272. 

See a full list of Daniel Gorman's publications.